Back

Amiodarone plus ranolazine for conversion of post-cardiac surgery atrial fibrillation: enhanced effectiveness in low versus preserved ejection fraction patients

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Atrial fibrillation - Ablation 2 Rhythm Control, Antiarrhythmic Drugs ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor John Skoularigis

University General Hospital of Larissa, Larissa (Greece)

6 More presentations in this session

Presentation thumbnail
Multivariate analysis of risk factors for recurrence in patients undergoing second generation cryoballoon ablation due to persistent atrial fibrillation: do vagal reactions play a predictive role?
Doctor D. Guckel (Bad Oeynhausen, DE)
Abstract
Presentation thumbnail
Five-year outcome and predictors of success after second-generation cryoballoon ablation for treatment of symptomatic atrial fibrillation
Doctor A. Berkowitsch (Bad Nauheim, DE)
Abstract
Presentation thumbnail
The effect of pulmonary vein anatomy on outcome of catheter ablation for atrial fibrillation
Doctor S. Istratoaie (Cluj Napoca, RO)
Abstract Slides
Presentation thumbnail
The use of cardiac imaging technologies before the pulmonary vein cryoablation for recurrent AF: data from a multicenter observational project.
Doctor G. Arena (Massa, IT)
Abstract
Presentation thumbnail
Factors associated with quality-of-life improvement after catheter ablation of asymptomatic persistent atrial fibrillation: insights from the Kansai Plus Atrial Fibrillation (KPAF) Registry
Doctor T. Kanda (Osaka, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Atrial fibrillation - Ablation 2

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources